Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Hartaj Singh's Stock Ratings
Oppenheimer Analyst
Hartaj Singh is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/04/2025
Overall Average Return
-10.1%
Smart Score
Overall Average Return Percentile
21st
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/25/2025 | GILD | Buy Now | Gilead Sciences | $103.68 | 20.56% | Hartaj Singh47% | $132 → $125 | Maintains | Outperform | Get Alert |
| 03/04/2025 | GILD | Buy Now | Gilead Sciences | $103.68 | 27.31% | Hartaj Singh47% | $115 → $132 | Maintains | Outperform | Get Alert |
| 12/11/2024 | SPRB | Buy Now | Spruce Biosciences | — | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 11/14/2024 | ATXS | Buy Now | Astria Therapeutics | $5.36 | 422.39% | Hartaj Singh47% | $26 → $28 | Maintains | Outperform | Get Alert |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $103.68 | 1.27% | Hartaj Singh47% | $95 → $105 | Maintains | Outperform | Get Alert |
| 11/06/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | 65.26% | Hartaj Singh47% | $1150 → $1000 | Maintains | Outperform | Get Alert |
| 10/31/2024 | UTHR | Buy Now | United Therapeutics | $294.60 | 103.67% | Hartaj Singh47% | $575 → $600 | Maintains | Outperform | Get Alert |
| 10/30/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | 7.61% | Hartaj Singh47% | $550 → $540 | Maintains | Outperform | Get Alert |
| 09/13/2024 | MRNA | Buy Now | Moderna | $27.40 | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 08/28/2024 | UTHR | Buy Now | United Therapeutics | $294.60 | 95.18% | Hartaj Singh47% | $400 → $575 | Maintains | Outperform | Get Alert |
| 08/13/2024 | ATXS | Buy Now | Astria Therapeutics | $5.36 | 385.07% | Hartaj Singh47% | $25 → $26 | Maintains | Outperform | Get Alert |
| 08/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | 9.61% | Hartaj Singh47% | $500 → $550 | Maintains | Outperform | Get Alert |
| 06/13/2024 | SPRB | Buy Now | Spruce Biosciences | — | — | Hartaj Singh47% | $4 → $3 | Maintains | Outperform | Get Alert |
| 06/12/2024 | CLLS | Buy Now | Cellectis | $1.65 | 506.1% | Hartaj Singh47% | $11 → $10 | Maintains | Outperform | Get Alert |
| 06/12/2024 | MRNA | Buy Now | Moderna | $27.40 | 553.28% | Hartaj Singh47% | $163 → $179 | Maintains | Outperform | Get Alert |
| 05/30/2024 | BMEA | Buy Now | Biomea Fusion | $2.25 | 2566.67% | Hartaj Singh47% | $70 → $60 | Maintains | Outperform | Get Alert |
| 05/23/2024 | VIRX | Buy Now | Viracta Therapeutics | — | — | Hartaj Singh47% | $13 → $11 | Maintains | Outperform | Get Alert |
| 05/21/2024 | ATXS | Buy Now | Astria Therapeutics | $5.36 | 366.42% | Hartaj Singh47% | $29 → $25 | Maintains | Outperform | Get Alert |
| 05/14/2024 | SRPT | Buy Now | Sarepta Therapeutics | $64.11 | 180.78% | Hartaj Singh47% | → $180 | Upgrade | Perform → Outperform | Get Alert |
| 05/03/2024 | MRNA | Buy Now | Moderna | $27.40 | 494.89% | Hartaj Singh47% | $142 → $163 | Maintains | Outperform | Get Alert |
| 05/02/2024 | UTHR | Buy Now | United Therapeutics | $294.60 | 35.78% | Hartaj Singh47% | $375 → $400 | Maintains | Outperform | Get Alert |
| 04/23/2024 | GANX | Buy Now | Gain Therapeutics | $2.28 | 294.74% | Hartaj Singh47% | → $9 | Maintains | Outperform | Get Alert |
| 04/19/2024 | GILD | Buy Now | Gilead Sciences | $103.68 | 1.27% | Hartaj Singh47% | $105 → $105 | Maintains | Outperform | Get Alert |
| 04/17/2024 | VIRX | Buy Now | Viracta Therapeutics | — | — | Hartaj Singh47% | → $13 | Maintains | Outperform | Get Alert |
| 04/15/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -0.36% | Hartaj Singh47% | → $500 | Maintains | Outperform | Get Alert |
| 04/03/2024 | BMEA | Buy Now | Biomea Fusion | $2.25 | 3011.11% | Hartaj Singh47% | → $70 | Maintains | Outperform | Get Alert |
| 03/26/2024 | ATXS | Buy Now | Astria Therapeutics | $5.36 | 441.04% | Hartaj Singh47% | $25 → $29 | Maintains | Outperform | Get Alert |
| 03/26/2024 | HARP | Buy Now | Harpoon Therapeutics | — | — | Hartaj Singh47% | — | Maintains | Outperform | Get Alert |
| 03/08/2024 | INO | Buy Now | Inovio Pharmaceuticals | $1.95 | 1951.28% | Hartaj Singh47% | $40 → $40 | Maintains | Outperform | Get Alert |
| 02/12/2024 | GILD | Buy Now | Gilead Sciences | $103.68 | 1.27% | Hartaj Singh47% | $115 → $105 | Maintains | Outperform | Get Alert |
| 01/25/2024 | INO | Buy Now | Inovio Pharmaceuticals | $1.95 | 105.13% | Hartaj Singh47% | → $4 | Upgrade | Perform → Outperform | Get Alert |
| 01/05/2024 | TRDA | Buy Now | Entrada Therapeutics | $9.23 | 138.35% | Hartaj Singh47% | → $22 | Initiates | → Outperform | Get Alert |
| 01/05/2024 | HARP | Buy Now | Harpoon Therapeutics | — | — | Hartaj Singh47% | → $23 | Initiates | → Outperform | Get Alert |
| 01/02/2024 | MRNA | Buy Now | Moderna | $27.40 | 418.25% | Hartaj Singh47% | → $142 | Upgrade | Perform → Outperform | Get Alert |
| 11/15/2023 | ATXS | Buy Now | Astria Therapeutics | $5.36 | 366.42% | Hartaj Singh47% | $30 → $25 | Maintains | Outperform | Get Alert |
| 10/02/2023 | ICVX | Buy Now | Icosavax | — | — | Hartaj Singh47% | → $25 | Reiterates | Outperform → Outperform | Get Alert |
| 09/13/2023 | OPT | Buy Now | Opthea | $3.96 | 304.03% | Hartaj Singh47% | $31 → $16 | Maintains | Outperform | Get Alert |
| 08/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | 73.53% | Hartaj Singh47% | $950 → $1050 | Maintains | Outperform | Get Alert |
| 08/18/2023 | SPRB | Buy Now | Spruce Biosciences | — | — | Hartaj Singh47% | $8 → $7 | Maintains | Outperform | Get Alert |
| 08/08/2023 | CLLS | Buy Now | Cellectis | $1.65 | 566.71% | Hartaj Singh47% | → $11 | Reiterates | Outperform → Outperform | Get Alert |
| 08/04/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | 57% | Hartaj Singh47% | $900 → $950 | Maintains | Outperform | Get Alert |
| 08/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -18.29% | Hartaj Singh47% | → $410 | Reiterates | Outperform → Outperform | Get Alert |
| 07/11/2023 | ELOX | Buy Now | Eloxx Pharmaceuticals | — | — | Hartaj Singh47% | $50 → $55 | Maintains | Outperform | Get Alert |
| 07/05/2023 | LIFE | Buy Now | aTyr Pharma | — | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 06/12/2023 | GANX | Buy Now | Gain Therapeutics | $2.28 | 338.6% | Hartaj Singh47% | → $10 | Reiterates | Outperform → Outperform | Get Alert |
| 06/08/2023 | ATXS | Buy Now | Astria Therapeutics | $5.36 | 459.7% | Hartaj Singh47% | → $30 | Reiterates | Outperform → Outperform | Get Alert |
| 05/26/2023 | SRPT | Buy Now | Sarepta Therapeutics | $64.11 | 180.78% | Hartaj Singh47% | → $180 | Reiterates | Outperform → Outperform | Get Alert |
| 05/23/2023 | SPRB | Buy Now | Spruce Biosciences | — | — | Hartaj Singh47% | → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -18.29% | Hartaj Singh47% | $350 → $410 | Maintains | Outperform | Get Alert |
| 04/25/2023 | ICVX | Buy Now | Icosavax | — | — | Hartaj Singh47% | → $27 | Reiterates | → Outperform | Get Alert |
| 04/11/2023 | BMEA | Buy Now | Biomea Fusion | $2.25 | 1988.89% | Hartaj Singh47% | → $47 | Reiterates | → Outperform | Get Alert |
| 04/06/2023 | ELOX | Buy Now | Eloxx Pharmaceuticals | — | — | Hartaj Singh47% | → $50 | Reiterates | → Outperform | Get Alert |
| 04/04/2023 | ONCT | Buy Now | Oncternal Therapeutics | — | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 03/29/2023 | BMEA | Buy Now | Biomea Fusion | $2.25 | 1988.89% | Hartaj Singh47% | $25 → $47 | Maintains | Outperform | Get Alert |
| 03/27/2023 | VIRX | Buy Now | Viracta Therapeutics | — | — | Hartaj Singh47% | $14 → $16 | Maintains | Outperform | Get Alert |
| 03/22/2023 | ONCT | Buy Now | Oncternal Therapeutics | — | — | Hartaj Singh47% | $280 → $180 | Maintains | Outperform | Get Alert |
| 03/13/2023 | OPT | Buy Now | Opthea | $3.96 | 682.81% | Hartaj Singh47% | $36 → $31 | Maintains | Outperform | Get Alert |
| 03/13/2023 | CLLS | Buy Now | Cellectis | $1.65 | 687.93% | Hartaj Singh47% | $16 → $13 | Maintains | Outperform | Get Alert |
| 03/09/2023 | SRPT | Buy Now | Sarepta Therapeutics | $64.11 | 133.99% | Hartaj Singh47% | $180 → $150 | Maintains | Outperform | Get Alert |
| 03/01/2023 | SRPT | Buy Now | Sarepta Therapeutics | $64.11 | 180.78% | Hartaj Singh47% | $150 → $180 | Maintains | Outperform | Get Alert |
| 01/04/2023 | ICVX | Buy Now | Icosavax | — | — | Hartaj Singh47% | → $27 | Initiates | → Outperform | Get Alert |
| 11/25/2022 | GANX | Buy Now | Gain Therapeutics | $2.28 | 338.6% | Hartaj Singh47% | $30 → $10 | Maintains | Outperform | Get Alert |
| 11/17/2022 | SPRB | Buy Now | Spruce Biosciences | — | — | Hartaj Singh47% | $13 → $8 | Maintains | Outperform | Get Alert |
| 11/11/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -30.25% | Hartaj Singh47% | → $350 | Maintains | Outperform | Get Alert |
| 11/03/2022 | UTHR | Buy Now | United Therapeutics | $294.60 | 27.29% | Hartaj Singh47% | $325 → $375 | Maintains | Outperform | Get Alert |
| 10/21/2022 | NBSE | Buy Now | NeuBase Therapeutics | — | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 05/11/2022 | INO | Buy Now | Inovio Pharmaceuticals | $1.95 | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 04/04/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -30.25% | Hartaj Singh47% | $305 → $350 | Maintains | Outperform | Get Alert |
| 02/08/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | 28.08% | Hartaj Singh47% | $825 → $775 | Maintains | Outperform | Get Alert |
| 12/17/2021 | SPRB | Buy Now | Spruce Biosciences | — | — | Hartaj Singh47% | → $15 | Initiates | → Outperform | Get Alert |
| 12/17/2021 | BMEA | Buy Now | Biomea Fusion | $2.25 | 877.78% | Hartaj Singh47% | → $22 | Initiates | → Outperform | Get Alert |
| 12/17/2021 | ELOX | Buy Now | Eloxx Pharmaceuticals | — | — | Hartaj Singh47% | → $160 | Initiates | → Outperform | Get Alert |
| 12/09/2021 | SRPT | Buy Now | Sarepta Therapeutics | $64.11 | 94.99% | Hartaj Singh47% | → $125 | Upgrade | Perform → Outperform | Get Alert |
| 09/14/2021 | LIFE | Buy Now | aTyr Pharma | — | — | Hartaj Singh47% | $14 → $20 | Maintains | Outperform | Get Alert |
| 08/06/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | 36.34% | Hartaj Singh47% | $725 → $825 | Maintains | Outperform | Get Alert |
| 08/06/2021 | MRNA | Buy Now | Moderna | $27.40 | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 04/16/2021 | FSTX | Buy Now | F-star Therapeutics | — | — | Hartaj Singh47% | → $30 | Initiates | → Outperform | Get Alert |
| 04/12/2021 | GANX | Buy Now | Gain Therapeutics | $2.28 | 1215.79% | Hartaj Singh47% | → $30 | Initiates | → Outperform | Get Alert |
| 04/07/2021 | ONCT | Buy Now | Oncternal Therapeutics | — | — | Hartaj Singh47% | → $280 | Initiates | → Outperform | Get Alert |
| 03/24/2021 | LIFE | Buy Now | aTyr Pharma | — | — | Hartaj Singh47% | $12 → $14 | Maintains | Outperform | Get Alert |
| 03/11/2021 | CATB | Buy Now | Catabasis Pharmaceuticals | — | — | Hartaj Singh47% | → $30 | Upgrade | Perform → Outperform | Get Alert |
| 02/23/2021 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | Hartaj Singh47% | → $42 | Upgrade | Perform → Outperform | Get Alert |
| 02/16/2021 | UTHR | Buy Now | United Therapeutics | $294.60 | -6.65% | Hartaj Singh47% | $200 → $275 | Maintains | Outperform | Get Alert |
| 02/12/2021 | INO | Buy Now | Inovio Pharmaceuticals | $1.95 | 1694.87% | Hartaj Singh47% | → $420 | Initiates | → Outperform | Get Alert |
| 02/01/2021 | MRNA | Buy Now | Moderna | $27.40 | 651.82% | Hartaj Singh47% | $178 → $206 | Maintains | Outperform | Get Alert |
| 11/11/2020 | OPT | Buy Now | Opthea | $3.96 | 809.07% | Hartaj Singh47% | → $36 | Initiates | → Outperform | Get Alert |
| 10/27/2020 | CATB | Buy Now | Catabasis Pharmaceuticals | — | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 09/10/2020 | GILD | Buy Now | Gilead Sciences | $103.68 | 1.27% | Hartaj Singh47% | $90 → $105 | Maintains | Outperform | Get Alert |
| 07/30/2020 | UTHR | Buy Now | United Therapeutics | $294.60 | -43.99% | Hartaj Singh47% | $155 → $165 | Maintains | Outperform | Get Alert |
| 07/16/2020 | CLSN | Buy Now | Celsion | — | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 07/01/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | 11.55% | Hartaj Singh47% | $625 → $675 | Maintains | Outperform | Get Alert |
| 06/24/2020 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 05/01/2020 | GILD | Buy Now | Gilead Sciences | $103.68 | -13.19% | Hartaj Singh47% | $80 → $90 | Maintains | Outperform | Get Alert |
| 04/30/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -39.22% | Hartaj Singh47% | $265 → $305 | Maintains | Outperform | Get Alert |
| 04/15/2020 | MRNA | Buy Now | Moderna | $27.40 | 56.93% | Hartaj Singh47% | $31 → $43 | Maintains | Outperform | Get Alert |
| 04/01/2020 | NBSE | Buy Now | NeuBase Therapeutics | — | — | Hartaj Singh47% | $280 → $340 | Maintains | Outperform | Get Alert |
| 03/17/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 03/11/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | -13.24% | Hartaj Singh47% | $450 → $525 | Maintains | Outperform | Get Alert |
| 03/02/2020 | LIFE | Buy Now | aTyr Pharma | — | — | Hartaj Singh47% | → $8 | Initiates | → Outperform | Get Alert |
| 01/08/2020 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -47.19% | Hartaj Singh47% | $230 → $265 | Maintains | Outperform | Get Alert |
| 11/21/2019 | NBSE | Buy Now | NeuBase Therapeutics | — | — | Hartaj Singh47% | → $280 | Initiates | → Outperform | Get Alert |
| 10/25/2019 | GILD | Buy Now | Gilead Sciences | $103.68 | -22.84% | Hartaj Singh47% | $85 → $80 | Maintains | Outperform | Get Alert |
| 03/07/2019 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -54.17% | Hartaj Singh47% | $200 → $230 | Maintains | Outperform | Get Alert |
| 01/03/2019 | GILD | Buy Now | Gilead Sciences | $103.68 | — | Hartaj Singh47% | — | Upgrade | Perform → Outperform | Get Alert |
| 01/02/2019 | MRNA | Buy Now | Moderna | $27.40 | -1.46% | Hartaj Singh47% | → $27 | Initiates | → Outperform | Get Alert |
| 11/01/2018 | SLS | Buy Now | SELLAS Life Sciences Gr | $1.77 | 634.5% | Hartaj Singh47% | → $650 | Initiates | → Outperform | Get Alert |
| 06/27/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | — | Hartaj Singh47% | — | Upgrade | Perform → Outperform | Get Alert |
| 06/12/2018 | CLLS | Buy Now | Cellectis | $1.65 | 2566.83% | Hartaj Singh47% | $40 → $44 | Maintains | Outperform | Get Alert |
| 06/12/2018 | ARQL | Buy Now | Arqule | — | — | Hartaj Singh47% | → $7 | Initiates | → Outperform | Get Alert |
| 05/04/2018 | SRPT | Buy Now | Sarepta Therapeutics | $64.11 | — | Hartaj Singh47% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 01/26/2018 | SMMT | Buy Now | Summit Therapeutics | $27.99 | 7.18% | Hartaj Singh47% | $24 → $30 | Maintains | Outperform | Get Alert |
| 11/21/2017 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | Hartaj Singh47% | — | Initiates | → Outperform | Get Alert |
| 11/21/2017 | CLSN | Buy Now | Celsion | — | — | Hartaj Singh47% | → $135 | Initiates | → Outperform | Get Alert |
| 10/05/2017 | GILD | Buy Now | Gilead Sciences | $103.68 | — | Hartaj Singh47% | — | Initiates | → Perform | Get Alert |
| 07/28/2017 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Hartaj Singh47% | — | Upgrade | Perform → Outperform | Get Alert |
| 06/02/2017 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | — | Hartaj Singh47% | — | Upgrade | Perform → Outperform | Get Alert |
| 12/15/2016 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Hartaj Singh47% | — | Initiates | → Perform | Get Alert |
| 12/15/2016 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | — | Hartaj Singh47% | — | Initiates | → Perform | Get Alert |
| 12/14/2016 | UTHR | Buy Now | United Therapeutics | $294.60 | — | Hartaj Singh47% | — | Initiates | → Outperform | Get Alert |
| 05/02/2016 | SRPT | Buy Now | Sarepta Therapeutics | $64.11 | — | Hartaj Singh47% | — | Upgrade | Perform → Outperform | Get Alert |
| 04/26/2016 | SRPT | Buy Now | Sarepta Therapeutics | $64.11 | — | Hartaj Singh47% | — | Downgrade | Outperform → Perform | Get Alert |
| 04/06/2016 | SRPT | Buy Now | Sarepta Therapeutics | $64.11 | -6.41% | Hartaj Singh47% | $45 → $60 | Maintains | Outperform | Get Alert |
| 02/11/2016 | GILD | Buy Now | Gilead Sciences | $103.68 | 15.74% | Hartaj Singh47% | → $120 | Initiates | → Outperform | Get Alert |
| 02/11/2016 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | — | Hartaj Singh47% | — | Assumes | → Perform | Get Alert |
| 02/03/2016 | GILD | Buy Now | Gilead Sciences | $103.68 | 15.74% | Hartaj Singh47% | $124 → $120 | Maintains | Outperform | Get Alert |
| 10/20/2015 | GILD | Buy Now | Gilead Sciences | $103.68 | 19.6% | Hartaj Singh47% | $120 → $124 | Maintains | Outperform | Get Alert |
| 07/20/2015 | CATB | Buy Now | Catabasis Pharmaceuticals | — | — | Hartaj Singh47% | → $1680 | Initiates | → Outperform | Get Alert |
| 05/22/2015 | CLLS | Buy Now | Cellectis | $1.65 | 3839.63% | Hartaj Singh47% | → $65 | Initiates | → Outperform | Get Alert |
| 04/27/2015 | GILD | Buy Now | Gilead Sciences | $103.68 | — | Hartaj Singh47% | — | Assumes | → Outperform | Get Alert |
| 04/27/2015 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | — | Hartaj Singh47% | — | Assumes | → Perform | Get Alert |
| 04/27/2015 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Hartaj Singh47% | — | Assumes | → Outperform | Get Alert |
| 07/08/2014 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | — | Hartaj Singh47% | — | Initiates | → Market Perform | Get Alert |
| 02/13/2014 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | -46.29% | Hartaj Singh47% | $31 → $325 | Downgrade | Outperform → Market Perform | Get Alert |
| 09/30/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | -48.77% | Hartaj Singh47% | $300 → $310 | Maintains | Outperform | Get Alert |
| 08/21/2013 | VRTX | Buy Now | Vertex Pharmaceuticals | $501.80 | -79.08% | Hartaj Singh47% | → $105 | Initiates | → Outperform | Get Alert |
| 08/21/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | -50.42% | Hartaj Singh47% | → $300 | Initiates | → Outperform | Get Alert |
| 08/21/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $605.10 | -50.42% | Hartaj Singh47% | → $300 | Initiates | → Outperform | Get Alert |
| 03/14/2013 | GILD | Buy Now | Gilead Sciences | $103.68 | -51.77% | Hartaj Singh47% | $45 → $50 | Maintains | Outperform | Get Alert |
| 02/14/2013 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Hartaj Singh47% | $134 → $115 | Maintains | Outperform | Get Alert |
| 03/29/2012 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Hartaj Singh47% | $89 → $100 | Maintains | Outperform | Get Alert |
